Bodh I. Jugdutt
Division of Cardiology
Walter MacKenzie Health Sciences Centre
University of Alberta
Edmonton
Canada
Name/email consistency: high
- Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker. Jugdutt, B.I., Jelani, A., Palaniyappan, A., Idikio, H., Uweira, R.E., Menon, V., Jugdutt, C.E. Circulation (2010)
- Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly. Jugdutt, B.I. Clin. Interv. Aging (2010)
- Role of healing-specific-matricellular proteins and matrix metalloproteinases in age-related enhanced early remodeling after reperfused STEMI in dogs. Jugdutt, B.I., Palaniyappan, A., Uwiera, R.R., Idikio, H. Mol. Cell. Biochem. (2009)
- Current and novel cardiac support therapies. Jugdutt, B.I. Curr. Heart. Fail. Rep (2009)
- Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly. Jugdutt, B.I. Heart. Fail. Rev (2008)
- Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets. Jugdutt, B.I. Curr. Drug. Targets (2008)
- Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction. Jugdutt, B.I., Idikio, H., Uwiera, R.R. Mol. Cell. Biochem. (2007)
- Therapeutic drugs during healing after myocardial infarction modify infarct collagens and ventricular distensibility at elevated pressures. Jugdutt, B.I., Idikio, H., Uwiera, R.R. Mol. Cell. Biochem. (2007)
- Valsartan in the treatment of heart attack survivors. Jugdutt, B.I. Vasc. Health. Risk. Manag (2006)
- Apoptosis and oncosis in acute coronary syndromes: assessment and implications. Jugdutt, B.I., Idikio, H.A. Mol. Cell. Biochem. (2005)
- AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction. Jugdutt, B.I., Menon, V. Mol. Cell. Biochem. (2004)
- AT1 receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: detection using proteomics. Jugdutt, B.I., Sawicki, G. Mol. Cell. Biochem. (2004)
- AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat. Jugdutt, B.I., Menon, V. Mol. Cell. Biochem. (2004)
- Nitric oxide and cardiovascular protection. Jugdutt, B.I. Heart. Fail. Rev (2003)
- Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Jugdutt, B.I. Curr. Drug. Targets. Cardiovasc. Haematol. Disord (2003)
- Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?. Jugdutt, B.I. Circulation (2003)
- Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat. Jugdutt, B.I., Menon, V. J. Cardiovasc. Pharmacol. Ther. (2003)
- Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril. Jugdutt, B.I., Menon, V., Kumar, D., Idikio, H. J. Am. Coll. Cardiol. (2002)
- Nitric oxide in heart failure: friend or foe. Jugdutt, B.I. Heart. Fail. Rev (2002)
- Nitric oxide and cardioprotection during ischemia-reperfusion. Jugdutt, B.I. Heart. Fail. Rev (2002)
- Enhanced regional AT(2)-receptor and PKC(epsilon) expression during cardioprotection induced by AT(1)-receptor blockade after reperfused myocardial infarction. Jugdutt, B.I., Balghith, M. J. Renin. Angiotensin. Aldosterone. Syst (2001)
